SCHEMBL8360731

SCHEMBL8360731

CN1C(=O)CN(Cc2cccc(F)n2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
SCN9A Q15858 2/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
TAS2R8 Q9NYW2 4/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
PDE4A P27815 1/20 0.35
PARG Q86W56 1/20 0.34
RIPK1 Q13546 3/20 0.33
ENPP2 Q13822 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
MAPK1 P28482 1/20 0.32
MBOAT4 Q96T53 1/20 0.32
ALOX5 P09917 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
WDR5 P61964 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13924862 0.86 POLB (0.37) BCHEACHEPDE4ARIPK1PRMT5
SCHEMBL8363890 0.72 ALDH1A1 (0.51) TSHRTAS2R8MAPK1
SCHEMBL8360733 0.71 CYP11B1 (0.41) TAS2R8ENPP2WDR5
SCHEMBL25113570 0.71 TSHR (0.47) TSHRACHEMEN1KMT2A
SCHEMBL29480806 0.71 TSHR (0.47) TSHRACHEMEN1KMT2A
SCHEMBL8360736 0.70 IGF1R (0.42) TSHRTAS2R8ENPP2MAPK1WDR5
SCHEMBL8363896 0.70 PRMT5 (0.48) PRMT5WDR77MAPK1MEN1KMT2A
SCHEMBL7212064 0.70 ENPP2 (0.53) TSHRACHEENPP2MEN1KMT2A
SCHEMBL1815809 0.69 ENPP2 (0.41) TSHRSCN9ASCN10ATAS2R8ENPP2
SCHEMBL4146406 0.69 DDB1 (0.36) SCN9ABCHEACHEPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed
US-7452886-B2 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2008-11-18 US disclosed
US-7452886-B2 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2008-11-18 US disclosed
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases CTSK, CTSS, CTSZ TSHR 4339/4885SCN9A 4595/4885SCN10A 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.